Results 281 to 290 of about 5,576,002 (348)

Day/night variations of myeloid and lymphoid cell subsets in the murine inguinal lymph node

FEBS Open Bio, EarlyView.
The circadian system is involved in the temporal regulation of the immune system. Our study reveals that two innate immune populations, NKT cells and neutrophils, predominate at the beginning of the day in healthy mice, highlighting how the time of day influences immune responses.
Paula M. Wagner, César G. Prucca, Lucia Boffelli, Virginia A. Piqueras, Silvia G. Correa, Mariana Maccioni, Mario E. Guido   +6 more
wiley   +1 more source

Dissecting the role of KLF5: from tumor progression to immune interactions with emphasis on glioma and bladder cancer. [PDF]

Front Immunol
Yuan Z, Situ M, Ye Y, Zhang J, Jiang K, Zhang S, Deng X, He Z, Luo J, Wang Y.   +9 more
europepmc   +1 more source

ATG4B is required for mTORC1‐mediated anabolic activity and is associated with clinical outcomes in non‐small cell lung cancer

FEBS Open Bio, EarlyView.
The relationship between anabolic and catabolic processes governing lung cancer cell growth is nuanced. We show that ATG4B, an autophagy regulator, is elevated in lung cancer and that high ATG4B is associated with worse patient outcomes. Targeting ATG4B in cells reduces growth, protein synthesis, and mTORC1 activity, demonstrating a new relationship ...
Patrick J. Ryan, Bethany C. Guerra, Selina Uranga, Jessica M. Cardin, Steven E. Riechman, Mariana Janini Gomes, James D. Fluckey   +6 more
wiley   +1 more source

LHX2 Rewires the Metabolic and Epigenetic Landscape to Drive Tumor Progression in Prostate Cancer. [PDF]

Cancer Res
Jiang J, Liu S, Xu C, He L, Li H, Zhou Y, Li Z, Li Y, Yang F, Wei Y, Lu T, Zhang K, Zhang J, Wang P, Guo L, Shi C, Wen W, Zhang R, Han D, Qin W.   +19 more
europepmc   +1 more source

IL21-STAT3 controls the pentose phosphate pathway to support metabolic reprogramming and tumor progression in chronic lymphocytic leukemia. [PDF]

Hemasphere
Del Prete R, Tusha V, Simon-Molas H, Gazziero VA, Nardi F, Drago R, Bartolini G, Licastro D, Malchiodi M, Mariottini C, Marotta G, Caravagna G, Bruscoli S, Eldering E, Gozzetti A, Bocchia M, Kabanova A.   +16 more
europepmc   +1 more source

CSDE1 depletion inhibits tumor progression through enhancing B-cell infiltration in NSCLC. [PDF]

Cell Death Dis
Li W, Xiang S, Liu K, Wang Y, Li Q, OuYang Q, Zhan Y, Yu B, Chen H, Ge B, Cui J, Yin J, Guo A.   +12 more
europepmc   +1 more source

Pyroptosis in cancer therapy: a double-edged sword for immune activation and tumor progression. [PDF]

Mol Cancer
Alishvandi A, Aram C, Shahrivar FF, Kesharwani P, Sahebkar A.   +4 more
europepmc   +1 more source

AMIGO2 accelerates tumor progression by inducing a cancer stem cell-like phenotype. [PDF]

Sci Rep
Seong HK, Osaki M, Izutsu R, Jehung JP, Sato R, Sasaki R, Hamada J, Yamamoto A, Takenaka A, Okada F.   +9 more
europepmc   +1 more source

Correction to "Epigenetic Control of Translation Checkpoint and Tumor Progression via RUVBL1-EEF1A1 Axis". [PDF]

Adv Sci (Weinh)
europepmc   +1 more source

SDHA Deficiency in Hepatocellular Carcinoma Promotes Tumor Progression through Succinate-Induced M2 Macrophage Polarization. [PDF]

Oncol Res
Li X, Ma L, Shen C, Gu R, Dong S, Liu M, Xiao Y, Liu W, Liu Y, Zhao C.   +9 more
europepmc   +1 more source